Smart Inhalers Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

The global smart inhalers market was valued at USD 15.40 Billion in 2024, driven by the growing incidences of chronic respiratory diseases (CRDs) across the globe. The market is expected to grow at a CAGR of 19.40% during the forecast period of 2025-2034, with the values likely to reach USD 90.69 Billion by 2034.

Smart Inhalers Market Overview

Smart inhalers are medical equipment that can be connected to a smartphone or other digital device to monitor and track the health of patients suffering from respiratory disorders such as asthma and COPD. This type of device is equipped with sensors that can notify patients via smartphones about the dangers of highly polluted places or pollen-prone regions. They are also used to automatically track and monitor drug doses while maintaining a record of the patient's diagnosis history.

The rising prevalence of respiratory conditions such as asthma and COPD presents significant opportunities for the adoption of smart inhalers. For example, a 2016 study by the Centres for Disease Control and Prevention (CDC) reported that approximately 26.5 million people in the U.S. were affected by asthma. These factors are anticipated to significantly boost the market growth for smart inhalers.

The growing emphasis on developing smart inhalers, as well as increased R&D investments by key market players, are driving demand for smart inhalers. Furthermore, companies are including digital technology in their product offerings to improve pharmaceutical efficacy as well as asthma and COPD treatment. For example, in April 2022, Aptar Pharma launched Hero Tracker Sense, a chronic respiratory digital e-health solution that transforms a traditional metered dose inhaler into a smart one. In addition, several research studies showing the benefits of adopting smart inhalers, such as supporting patients in medication adherence and reducing symptoms, are also contributing to market expansion.

Smart Inhalers Market Growth Drivers

Growing Incidences of Chronic Respiratory Diseases to Drive Market Growth

The growing prevalence of chronic respiratory disorders such as COPD and asthma across the globe is creating increased demand for smart inhalation devices. The American Lung Association reported that 11.7 million people were diagnosed with COPD (chronic obstructive pulmonary disease), chronic bronchitis, or emphysema in 2022. This led to the adoption of digital inhalers for controlled drug delivery and patient health tracking. Furthermore, the shift in consumer preference from traditional medication delivery systems to smart drug delivery equipment due to advanced technologies and high accuracy in data collection is a major trend in the market. Hence, the rising cases and growing awareness of digital technology for the treatment of chronic respiratory diseases are expected to support the market growth of smart inhalers during the forecast period.

Smart Inhalers Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Integration of Advanced Technology in Smart Inhalers to Affect the Market Landscape Significantly

Advanced technologies, such as Bluetooth and Wi-Fi, are getting integrated into digital inhalers, allowing them to communicate with smartphones and enabling notification capabilities such as dosing remaining and dose monitoring algorithms. For example, in 2016, Propeller Health reported that patients who used smart inhalers saw a reduction in doctor visits of more than 60.0%. Furthermore, this equipment provides patient education tools that reduce dosing errors, resulting in lower hospitalization and treatment costs.

Launch of Innovative Products Poised to Augment Smart Inhalers Market Demand

Rising investments by key players in advanced technologies for smart inhaler devices have resulted in a high level of innovation, as industry players develop novel solutions such as inhalers with sensors, trackers, connectivity features, and integrated digital platforms to obtain improved patient health insights. For example, in July 2023, Teva UK planned to deliver the GoResp Digihaler system to asthma and COPD patients in the UK. This inhaler device has built-in sensors that collect and store patient data for future consultation and therapy.

Smart Inhalers Market Segmentation

The report titled “Smart Inhalers Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

• Metered Dose Inhalers
• Dry Powder Inhalers
• Others

Market Breakup by Indication

• Asthma
• Chronic Obstructive Pulmonary Disorders (COPD)
• Others

Market Breakup by End User

• Hospitals & Clinics
• Homecare Settings
• Others

Market Breakup by Distribution Channel

• Hospital Pharmacies
• Independent Pharmacies
• Online Pharmacies
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Smart Inhalers Market Share

The Product Type Holds a Significant Market Share

The market segmentation by product type is divided into metered dose inhalers, dry powder inhalers, and others. The dry powder inhaler is a device that is used for lung medication in the form of dry powder rather than using a chemical propellant to force the medication out of the device. The DPI releases it based on the patient's breathing capacity and can store up to 200 doses. With the rising incidence of chronic respiratory diseases around the world, the dry powder inhaler category is expected to dominate the market in the coming years. While there are a few limitations connected with the use of DPI, such as uneven drug dosage, increasing investments by various market participants to solve its technical faults will significantly assist the market expansion of this type of inhalers.

The metered dose inhalers are expected to witness robust growth in the smart inhalers market during the forecast period. These smart inhalers consist of a drug-filled canister that fits into a boot-shaped mouthpiece. The drug dosage is released into the patient's lungs by inserting the canister into the boot. The advantages of using MDI include the ability to monitor and regulate the amount of medicine disseminated as needed. The category is also expected to grow significantly over the projected period, as key businesses are focusing on R&D operations to manufacture revolutionary technology-incorporated medical devices. For example, Lupin introduced ADHERO, a revolutionary smart metered-dose inhaler in November 2019. The inhaler is designed to assist patients with acute respiratory disorders in tracking their MDI usage and improving medication adherence.

Smart Inhalers Market Analysis by Region

Regionally, North America is expected to dominate the market for smart inhalers owing to the rising burden of chronic respiratory diseases. The increasing adoption of innovative technologies, such as smart inhalers along with an aging population is expected to drive the market growth. Factors such as increased digitalization in the healthcare sector, favorable government policies, and a flexible regulatory environment with increased investment by government and domestic players of smart inhalers will drive regional growth throughout the forecast period.

Leading Players in the Global Smart Inhalers Market

The key features of the market report comprise the patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:

Sensirion AG

Headquartered in Stafa, Switzerland, Sensirion AG is a significant player in the market known for its high-quality smart inhaler devices. The company has a robust portfolio of smart inhalers supporting asthma and COPD patients during inhalation.

Aptar Group Inc.

Aptar Group Inc., an American multinational healthcare company based in Crystal Lake, Illinois, is a prominent player in the market. The company provides smart inhalers under a brand name called Hero Tracker Sense. It is a next-generation metered-dose inhaler (MDI) which offers healthcare providers (HCPs) valuable analytics and insights into patient training, onboarding, and performance through the Aptar Pharma Cohero Health BreatheSmart Connect Portal.

Other key players in the market include Novartis AG, Teva Pharmaceutical Ltd., Boehringer Ingelheim International GmbH, Adherium, and Findair Sp. z o. o.

Key Questions Answered in the Smart Inhalers Market Report

• What was the global smart inhalers market value in 2023?
• What is the global smart inhalers market forecast outlook for 2025-2034?
• What are the regional markets covered in the report?
• What is market segmentation based on product type?
• What is the market breakup based on application?
• Who are the major end users in the market?
• What are the major factors aiding the global smart inhalers market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• Which regional market is expected to lead the market share in the forecast period?
• Which country is expected to experience expedited growth during the forecast period?
• How does the prevalence and incidence of chronic diseases affect the market landscape?
• What are the major global smart inhalers market trends?
• How does the rise in the geriatric population impact the market size?
• Which product type will dominate the market share?
• Which application is expected to have a high market value in the coming years?
• Which end user is projected to contribute to the highest market growth?
• Who are the key players involved in the smart inhalers market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.